Downregulation of YTHDC1 promotes lung tumor progression and leads to ferroptosis resistance through m6A mediated upregulation of FSP1 protein levels, providing a treatment option for lung cancer with high YTHDC1 levels associated with ferroptosis (Yuan et al., 2023). Here, YTHDC1 is linked to lung carcinoma.